CAS NO: | 947687-13-0 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
25mg | 电议 |
50mg | 电议 |
生物活性 | Ramucirumab is a humanVEGFR-2antagonist for the treatment of solid tumors. Ramucirumab is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding ofVEGFRligands:VEGF-A,VEGF-C, andVEGF-D. Ramucirumab is also an angiogenesis inhibitor[1][2]. | |
IC50& Target[1][2] |
| |
体外研究 (In Vitro) | Ramucirumab (10 μg/mL) impedes both VEGF- and tumor-driven cord formation[3]. | |
Clinical Trial | ||
分子量 | 143609.63 | |
性状 | Liquid | |
Formula | C6374H9864N1692O1996S46 | |
CAS 号 | 947687-13-0 | |
中文名称 | 雷莫芦单抗 | |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |